Immune Response News and Research

RSS

Treatment helps 26% of black Americans with chronic hepatitis C

Twenty-six percent (26%) of black Americans (BA) with chronic hepatitis C who received treatment with Pegasys plus Copegus (peginterferon alfa-2a plus ribavirin) achieved a sustained virological response (SVR), according to study results published in the June 2004 issue of Hepatology.

1 Jun 2004

Antibiotics could be the cause of many allergies

Allergies making your life miserable? Tired of popping antihistamines like candy? Can't go anywhere without your inhaler? The real problem may not be your stuffed-up head. It could be the microbes in your gut.

27 May 2004

Link between oral bacterium and premature babies

For years, scientists have noticed a particular oral bacterium can be found in the amniotic fluid of about 20 percent of women with premature babies.

27 May 2004

Research tests the efficacy of a smallpox vaccine candidate known as LC16m8

When used as an aerosolized weapon, smallpox could be controlled by a new vaccine under study at Saint Louis University School of Medicine, according to new data.

27 May 2004

$3.5 million grant to develop AIDS vaccinations

Researchers at the Vaccine and Gene Therapy Institute (VGTI) and the Oregon National Primate Research Center at Oregon Health & Science University have received a $3.5 million grant from the National Institutes of Health to develop new methods for vaccinating humans against human immunodeficiency virus (HIV), the virus that causes AIDS.

25 May 2004

Bacteria found in the mouth can block the HIV virus

Certain strains of bacteria that occur naturally in the human mouth can snare the HIV virus and even cells it has infected, according to researchers at the University of Illinois at Chicago College of Dentistry. They report their findings today at the 104th General Meeting of the American Society for Microbiology.

25 May 2004

Researchers have isolated a protein receptor in chickens responsible for transferring antibodies from mother to offspring

Howard Hughes Medical Institute (HHMI) researchers have isolated a protein receptor in chickens that is responsible for transferring antibodies from mother to offspring - a function critical to bestowing a temporary immunity that protects the young against infection until their own immune systems begin functioning.

24 May 2004

Damage to the left half side of brain may make a right-handed person more susceptible to infection

A major immunological difference between the opposite halves of the human brain is now confirmed in a study published May 24, 2004 in the online edition of the Annals of Neurology. Researchers have found that damage or surgery to the left half of the brain may make a right-handed person more susceptible to being immunocompromised.

24 May 2004

Zinc may help to accelerate recovery from pneumonia

The addition of zinc to standard antimicrobial treatment may accelerate recovery from pneumonia, say researchers in this week's issue of The Lancet.

20 May 2004

Influenza vaccine does provide protection against influenza in most asthma patients taking inhaled steroids

The influenza vaccine protected asthma patients who use inhaled steroids against type A flu, although its protection against type B flu was significantly reduced in those taking high doses of inhaled steroids, said a researcher from Baylor College of Medicine in a recent publication.

15 May 2004

Study of hematopoietic stem cell transplantation for severe, treatment-resistant lupus

The study will include a basic research component to examine the roles of B and T cells, white blood cells in the immune system, in triggering lupus symptoms.

14 May 2004

New research program to focus on human beta cell regeneration and its potential role to cure type-1 diabetes

The Juvenile Diabetes Research Foundation (JDRF) have announced a new program today called the Regeneration of Beta Cell Function (RBCF) to focus on human beta cell regeneration and its potential role to cure type-1 diabetes.

14 May 2004

Viragen and University of Miami to advance anti-cancer study

Viragen, Inc. today announced that the Company extended its agreement with the University of Miami and UM/Sylvester Comprehensive Cancer Center to develop a novel form of an immune enhancing drug (IEP 11) that has shown promise in animal studies by inhibiting tumor growth in a broad range of cancers.

12 May 2004

Australian researchers are working on a vaccine to prevent rheumatic fever and rheumatic heart disease

The Queensland Institute of Medical Research (QIMR) Australia, is working on a vaccine to prevent rheumatic fever (RF) and rheumatic heart disease (RHD). Rheumatic fever and rheumatic heart disease are a secondary complication of a bacterial infection.

12 May 2004

Scientists closer to a potential vaccine or treatment for botulism

By deciphering the near atomic-level structure of the catalytic domain of botulinum toxin type E — one of seven neurotoxins that cause botulism, a disease that paralyzes victims by blocking nerve cells’ ability to communicate — scientists at the U.S. Department of Energy’s Brookhaven National Laboratory are one step closer to a potential vaccine or treatment.

10 May 2004

Discovery of immune system malfunction that plays a profound role in food allergy

A team of scientists, led by the Institute of Food Research (IFR) in the UK, has discovered an immune system malfunction that is likely to play a profound role in food allergy.

8 May 2004

International research team have decoded the genetic blueprint of the tularemia (rabbit fever) bacterium

Two teams of researchers, one based in the United States and the other in Europe, have decoded the genetic blueprint of the tularemia (rabbit fever) bacterium, a highly infectious human and animal pathogen.

6 May 2004

World's first gene therapy trial aimed at preventing cancer

The concept seems straightforward. If, at its heart, cancer is a disease of genes, then giving patients new genes should disarm cancer. Such treatment would replace missing or faulty genes that keep cell growth in check, or would flush the body with "super genes" that could attack and destroy cancer.

5 May 2004

UK researchers get 180,000 Euros to identify and develop new vaccines against Tuberculosis

A researcher from Birmingham University's School of Biosciences has won EU funding of 180,000 Euros to identify and develop new vaccines against Tuberculosis.

4 May 2004

New technique of identifying genes may help researchers developing drugs

A quick new technique able to identify genes that evolve rapidly as well as those that change slowly already has pinpointed new targets for researchers developing drugs against tuberculosis and malaria, and it could do the same for other infectious diseases, according to a paper in this week's Nature.

29 Apr 2004

Immune Response News and Research

Treatment helps 26% of black Americans with chronic hepatitis C

Antibiotics could be the cause of many allergies

Link between oral bacterium and premature babies

Research tests the efficacy of a smallpox vaccine candidate known as LC16m8

$3.5 million grant to develop AIDS vaccinations

Bacteria found in the mouth can block the HIV virus

Researchers have isolated a protein receptor in chickens responsible for transferring antibodies from mother to offspring

Damage to the left half side of brain may make a right-handed person more susceptible to infection

Zinc may help to accelerate recovery from pneumonia

Influenza vaccine does provide protection against influenza in most asthma patients taking inhaled steroids

Study of hematopoietic stem cell transplantation for severe, treatment-resistant lupus

New research program to focus on human beta cell regeneration and its potential role to cure type-1 diabetes

Viragen and University of Miami to advance anti-cancer study

Australian researchers are working on a vaccine to prevent rheumatic fever and rheumatic heart disease

Scientists closer to a potential vaccine or treatment for botulism

Discovery of immune system malfunction that plays a profound role in food allergy

International research team have decoded the genetic blueprint of the tularemia (rabbit fever) bacterium

World's first gene therapy trial aimed at preventing cancer

UK researchers get 180,000 Euros to identify and develop new vaccines against Tuberculosis

New technique of identifying genes may help researchers developing drugs

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News